Should You Buy, Sell or Hold Merck (MRK) Ahead of Q2 Earnings?
Merck (MRK) will report its second-quarter earnings on Jul 30, before market open. The Zacks Consensus Estimate for sales and earnings is pegged at 2.15 per share, respectively. Earnings estimates for Merck have risen from 8.60 per share over the past seven days. For 2025, earnings estimates have risen from 9.96 per share over the same timeframe.Image Source: Zacks Investment ResearchEarnings Surprise HistoryThe healthcare bellwether’s performance has been solid, with ...